Stryker Corporation (SYK)-医療機器分野:企業M&A・提携分析

◆英語タイトル:Stryker Corporation (SYK) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011705
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月13日
◆ページ数:136
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Stryker Corporation (Stryker) is one of the leading manufacturers of medical equipment. It offers reconstructive, medical and surgical, and neurotechnology and spine products. Its major products include implants; surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling and emergency medical equipment; neurosurgical, neurovascular and spinal devices; and medical devices used in a variety of medical specialties. It has R&D facilities in the US, France, Germany, India, Ireland, Puerto Rico and Switzerland. The company sells its products through its subsidiaries, branches, third-party dealers and distributors in the Americas, Europe, Asia-Pacific, the Middle East and Africa. Stryker is headquartered in Michigan, the US.

Stryker Corporation (SYK) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 6
List of Figures 7
Stryker Corporation, Medical Equipment, Deals By Year, 2011 to YTD 2017 8
Stryker Corporation, Medical Equipment Deals By Type, 2011 to YTD 2017 9
Stryker Corporation, Medical Equipment, Deals By Region, 2011 to YTD 2017 10
Stryker Corporation, Medical Equipment, Deals By Market, 2011 to YTD 2017 11
Stryker Corporation, Medical Equipment, Deals Summary, 2011 to YTD 2017 12
Stryker Corporation, Medical Equipment, Deal Details 15
Asset Purchase 15
Stryker Acquires Vertebral Augmentation Solutions Business from Becton, Dickinson 15
Stryker Acquires Minimally-Invasive Spine Surgery Portfolio from SafeWire 16
Stryker Acquires Neuro Portfolio Assets of Synergetics 17
Stryker Acquires Assets of CHG Hospital Beds 18
Stryker Acquires ENT Surgery Business Unit from Polyganics 19
Patient Safety Technologies To Acquire Patents From ClearCount Medical Solutions 20
Mako Surgical Completes Acquisition Of Orthopedic Assets Of Pipeline Biomedical 21
Stryker Acquires Spinal Implant Technologies From VertiFlex 22
Stryker Acquires MMP Portfolio From The TPL Group 23
Boston Scientific Sells Neurovascular Business Unit To Stryker 24
Venture Financing 26
Stanmore Implants Raises US$12.3 Million In Venture Financing Round 26
Pivot Medical Secures US$32 Million In Series C Financing 27
Stanmore Implants Secures US$6.4 Million In Financing 28
Pivot Medical Secures US$2 Million In Financing 29
Private Equity 30
Madison Dearborn Partners Completes Acquisition Of Sage Products, Maker Of Disposable Healthcare Products 30
Partnerships 32
LaunchPad Medical Enters into Licensing Agreement with Stryker 32
Stryker and AlloSource Enter into Distribution Partnership 33
EOS imaging Enters into Co-Promotion Agreement with Stryker 34
Ziehm Imaging Enters into Co-Marketing Agreement with Stryker 35
Osiris Therapeutics Enters into Agreement with Stryker for Viable Bone Matrix 36
Stryker Enters Into Agreement With NeuroLogica For BodyTom CT Scanner 37
IMRIS Enters Into Technology Integration Agreement With Stryker 38
Stryker Extends Co-Marketing Agreement With OrthoSensor 39
NeuroLogica Enters Into Co-Development Agreement With Stryker 40
Stryker Enters Into Co-Marketing Agreement With OrthoSensor For OrthoSensor Knee Trial 41
curasan To Terminate Distribution Agreement With Stryker 42
Corin Group Enters Into Distribution Agreement With MAKO Surgical 43
Sage Products Enters Into An Agreement With 3M Health Care 44
Equity Offering 45
Mako Surgical Completes Public Offering Of Common Stock For US$46 Million 45
Patient Safety Technologies Completes Private Placement Of Shares For US$3.5 Million 46
Patient Safety Technologies Completes Private Placement Of US$7.1 Million 47
Debt Offering 48
Stryker Prices Public Offering of 1.800% Notes Due 2019 for USD500 Million 48
Stryker Raises USD1 Billion in Public Offering of 4.625% Notes Due 2046 49
Stryker Raises USD750 Million in Public Offering of 2.625% Notes Due 2021 51
Stryker Raises USD750 Million in Public Offering of 2% Notes Due 2019 53
Stryker Raises USD1 Billion in Public Offering of 3.5% Notes Due 2026 55
Stryker Raises USD750 Million in Public Offering of 3.375% Notes Due 2025 57
Stryker Completes Public Offering Of Notes Due 2024 For US$600 Million 59
Stryker Completes Public Offering Of Notes Due 2044 For US$400 Million 61
Stryker Completes Public Offering Of Notes Due 2018 For US$600 Million 63
Stryker Completes Public Offering Of Notes Due 2043 For US$400 Million 65
Stryker Completes Public Offering Of Senior Unsecured Notes Due 2016 For US$750 Million 67
Asset Transactions 69
OLYMPUS Completes Acquisition Of OP-1 Product Line From Stryker 69
Acquisition 71
Stryker to Acquire Entellus Medical for USD662 Million 71
Stryker Acquires Novadaq Technologies for USD701 Million 73
Stryker to Acquire Instratek 75
Stryker Acquires Stanmore Implants from SIW Holdings for USD52 Million 76
Stryker Acquires Physio-Control for USD1.28 Billion 77
Stryker Acquires Sage Products from Madison Dearborn Partners for USD2.8 Billion 79
Stryker Acquires Muka Metal 81
Stryker Completes Acquisition of French, German and Asia Pacific Operations of Small Bone Innovations 82
Stryker Completes Acquisition Of Berchtold For US$172 Million 84
Stryker Completes Acquisition Of Patient Safety Technologies For US$120 Million 85
Stryker Completes Acquisition Of Pivot Medical, Orthopedic Device Company 87
Stryker Completes Acquisition Of Mako Surgical For US$1.6 Billion 88
Stryker Completes Acquisition of Trauson Holdings, Orthopaedic Products Manufacturer, For US$764 Million 90
Stryker Completes Acquisition Of Surpass Medical, Neurological Devices Maker, For Up To US$135 Million 92
Stryker Completes Acquisition Of Concentric Medical For US$135 Million 93
Stryker Completes Acquisition Of MEMOMETAL TECHNOLOGIES 95
Stryker Completes Acquisition Of Orthovita 96
Stryker Corporation – Key Competitors 98
Stryker Corporation – Key Employees 99
Stryker Corporation – Locations And Subsidiaries 101
Head Office 101
Other Locations & Subsidiaries 101
Business Unit 108
Recent Developments 109
Financial Announcements 109
Oct 26, 2017: Stryker reports third quarter 2017 results 109
Jul 27, 2017: Stryker reports second quarter 2017 results 111
Apr 25, 2017: Stryker reports first quarter 2017 results 112
Jan 24, 2017: Stryker reports 2016 results and 2017 outlook 113
Jan 10, 2017: Stryker provides 2016 preliminary net sales results 115
Oct 27, 2016: Stryker reports third quarter 2016 results 117
Jul 21, 2016: Stryker reports second quarter 2016 results 118
Apr 20, 2016: Stryker reports first quarter 2016 results 119
Jan 26, 2016: Stryker Reports 2015 Results and 2016 Outlook 120
Jan 12, 2016: Stryker Provides 2015 Preliminary Sales Results and Increases Adjusted Earnings Guidance 121
Corporate Communications 123
Aug 02, 2017: Stryker announces election of new Director, Mary K. Brainerd 123
Jan 26, 2016: Stryker Announces the Retirement of William R. Jellison and the promotion of Glenn S. Boehnlein to Vice President, Chief Financial Officer 124
Legal and Regulatory 125
Aug 09, 2017: Novadaq Receives Court Approval for Arrangement With Stryker 125
Product News 126
Oct 30, 2017: Just-in-time 3D implants set to transform tumour surgery 126
Aug 23, 2017: Stryker provides an update regarding Sage warning letter and revised financial guidance 128
03/04/2016: Stryker Receives FDA Clearance for Tritanium PL Posterior Lumbar Cage 129
Product Approvals 130
Mar 04, 2016: Stryker Receives FDA Clearance for Tritanium PL Posterior Lumbar Cage 130
Other Significant Developments 131
Oct 30, 2017: Strykers Performance Solutions Launches Practice Excellence Program to Help Physician Practices Drive Profitability, Efficiency & Quality Outcomes 131
Nov 14, 2016: Stryker announces multi-year partnership with Indo UK Institute of Health to deliver affordable orthopaedic care in India 132
Jul 20, 2016: Stryker Performance Solutions Launches Episode Performance Manager 133
Jun 29, 2016: Accenture Selected to Help Stryker Improve Operating Efficiencies 134
Apr 27, 2016: Stryker’s Performance Solutions Announces JointCOACH Engagement Platform Designed to Educate and Navigate Patients Through the Entire Episode of Joint Replacement Care 135
Appendix 136
Methodology 136
About GlobalData 136
Contact Us 136
Disclaimer 136

List of Tables
Stryker Corporation, Medical Equipment, Key Facts, 2016 2
Stryker Corporation, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Stryker Corporation, Medical Equipment, Deals By Year, 2011 to YTD 2017 8
Stryker Corporation, Medical Equipment Deals By Type, 2011 to YTD 2017 9
Stryker Corporation, Medical Equipment, Deals By Region, 2011 to YTD 2017 10
Stryker Corporation, Deals By Market, 2011 to YTD 2017 11
Stryker Corporation, Medical Equipment, Deals Summary, 2011 to YTD 2017 12
Stryker Acquires Vertebral Augmentation Solutions Business from Becton, Dickinson 15
Stryker Acquires Minimally-Invasive Spine Surgery Portfolio from SafeWire 16
Stryker Acquires Neuro Portfolio Assets of Synergetics 17
Stryker Acquires Assets of CHG Hospital Beds 18
Stryker Acquires ENT Surgery Business Unit from Polyganics 19
Patient Safety Technologies To Acquire Patents From ClearCount Medical Solutions 20
Mako Surgical Completes Acquisition Of Orthopedic Assets Of Pipeline Biomedical 21
Stryker Acquires Spinal Implant Technologies From VertiFlex 22
Stryker Acquires MMP Portfolio From The TPL Group 23
Boston Scientific Sells Neurovascular Business Unit To Stryker 24
Stanmore Implants Raises US$12.3 Million In Venture Financing Round 26
Pivot Medical Secures US$32 Million In Series C Financing 27
Stanmore Implants Secures US$6.4 Million In Financing 28
Pivot Medical Secures US$2 Million In Financing 29
Madison Dearborn Partners Completes Acquisition Of Sage Products, Maker Of Disposable Healthcare Products 30
LaunchPad Medical Enters into Licensing Agreement with Stryker 32
Stryker and AlloSource Enter into Distribution Partnership 33
EOS imaging Enters into Co-Promotion Agreement with Stryker 34
Ziehm Imaging Enters into Co-Marketing Agreement with Stryker 35
Osiris Therapeutics Enters into Agreement with Stryker for Viable Bone Matrix 36
Stryker Enters Into Agreement With NeuroLogica For BodyTom CT Scanner 37
IMRIS Enters Into Technology Integration Agreement With Stryker 38
Stryker Extends Co-Marketing Agreement With OrthoSensor 39
NeuroLogica Enters Into Co-Development Agreement With Stryker 40
Stryker Enters Into Co-Marketing Agreement With OrthoSensor For OrthoSensor Knee Trial 41
curasan To Terminate Distribution Agreement With Stryker 42
Corin Group Enters Into Distribution Agreement With MAKO Surgical 43
Sage Products Enters Into An Agreement With 3M Health Care 44
Mako Surgical Completes Public Offering Of Common Stock For US$46 Million 45
Patient Safety Technologies Completes Private Placement Of Shares For US$3.5 Million 46
Patient Safety Technologies Completes Private Placement Of US$7.1 Million 47
Stryker Prices Public Offering of 1.800% Notes Due 2019 for USD500 Million 48
Stryker Raises USD1 Billion in Public Offering of 4.625% Notes Due 2046 49
Stryker Raises USD750 Million in Public Offering of 2.625% Notes Due 2021 51
Stryker Raises USD750 Million in Public Offering of 2% Notes Due 2019 53
Stryker Raises USD1 Billion in Public Offering of 3.5% Notes Due 2026 55
Stryker Raises USD750 Million in Public Offering of 3.375% Notes Due 2025 57
Stryker Completes Public Offering Of Notes Due 2024 For US$600 Million 59
Stryker Completes Public Offering Of Notes Due 2044 For US$400 Million 61
Stryker Completes Public Offering Of Notes Due 2018 For US$600 Million 63
Stryker Completes Public Offering Of Notes Due 2043 For US$400 Million 65
Stryker Completes Public Offering Of Senior Unsecured Notes Due 2016 For US$750 Million 67
OLYMPUS Completes Acquisition Of OP-1 Product Line From Stryker 69
Stryker to Acquire Entellus Medical for USD662 Million 71
Stryker Acquires Novadaq Technologies for USD701 Million 73
Stryker to Acquire Instratek 75
Stryker Acquires Stanmore Implants from SIW Holdings for USD52 Million 76
Stryker Acquires Physio-Control for USD1.28 Billion 77
Stryker Acquires Sage Products from Madison Dearborn Partners for USD2.8 Billion 79
Stryker Acquires Muka Metal 81
Stryker Completes Acquisition of French, German and Asia Pacific Operations of Small Bone Innovations 82
Stryker Completes Acquisition Of Berchtold For US$172 Million 84
Stryker Completes Acquisition Of Patient Safety Technologies For US$120 Million 85
Stryker Completes Acquisition Of Pivot Medical, Orthopedic Device Company 87
Stryker Completes Acquisition Of Mako Surgical For US$1.6 Billion 88
Stryker Completes Acquisition of Trauson Holdings, Orthopaedic Products Manufacturer, For US$764 Million 90
Stryker Completes Acquisition Of Surpass Medical, Neurological Devices Maker, For Up To US$135 Million 92
Stryker Completes Acquisition Of Concentric Medical For US$135 Million 93
Stryker Completes Acquisition Of MEMOMETAL TECHNOLOGIES 95
Stryker Completes Acquisition Of Orthovita 96
Stryker Corporation, Key Competitors 98
Stryker Corporation, Key Employees 99
Stryker Corporation, Other Locations 101
Stryker Corporation, Subsidiaries 102
Stryker Corporation, Business Unit 108

★海外企業調査レポート[Stryker Corporation (SYK)-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Utah Medical Products Inc (UTMD):企業の財務・戦略的SWOT分析
    Summary Utah Medical Products Inc (Utah Medical) is a medical device company that offers disposable and reusable products. The company offers blood pressure monitoring and blood management, gynecology, perinatology, urology and electrosurgery, respiratory and OEM products. Its blood pressure monitor …
  • Alliant Credit Union:企業の戦略的SWOT分析
    Alliant Credit Union - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • LIG Nex1 Co Ltd:企業の戦略・SWOT・財務分析
    LIG Nex1 Co Ltd - Strategy, SWOT and Corporate Finance Report Summary LIG Nex1 Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Krka dd Novo Mesto (KRKG):企業の財務・戦略的SWOT分析
    Summary Krka dd Novo Mesto (Krka) is a manufacturer and distributor of pharmaceutical products. The company provides prescription pharmaceuticals, non-prescription products, and animal health products. It offers prescription products for cardiovascular diseases, diseases of alimentary tract and meta …
  • National Gas & Industrial Co (2080):企業の財務・戦略的SWOT分析
    National Gas & Industrial Co (2080) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Protagen AG:企業のM&A・事業提携・投資動向
    Protagen AG - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Protagen AG Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, ca …
  • PF Atlantic Petroleum (ATLA DKK):石油・ガス:M&Aディール及び事業提携情報
    Summary P/F Atlantic Petroleum (Atlantic Petroleum) is an oil and gas company that offers development of offshore oil projects. The company's services include exploration, appraisal, development, and production programs. It operates its oil and gas interests in the Norwegian Continental Shelf, the U …
  • Convenience Retail Asia Limited:企業の戦略・SWOT・財務情報
    Convenience Retail Asia Limited - Strategy, SWOT and Corporate Finance Report Summary Convenience Retail Asia Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Yiaco Medical Co:企業の戦略的SWOT分析
    Yiaco Medical Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Costco Wholesale Corporation:企業の戦略・SWOT・財務情報
    Costco Wholesale Corporation - Strategy, SWOT and Corporate Finance Report Summary Costco Wholesale Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Teijin Pharma Ltd-医療機器分野:企業M&A・提携分析
    Summary Teijin Pharma Ltd (Teijin Pharma), a subsidiary of Teijin Ltd develops, manufactures and markets pharmaceutical and home healthcare products. The company offers a range of pharmaceutical products for the treatment of bone and joint diseases, respiratory diseases and cardiovascular and metabo …
  • JG Summit Holdings Inc:戦略・SWOT・企業財務分析
    JG Summit Holdings Inc - Strategy, SWOT and Corporate Finance Report Summary JG Summit Holdings Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Mecklenburg Electric Cooperative:企業の戦略的SWOT分析
    Mecklenburg Electric Cooperative - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pr …
  • U.P. Hotels Ltd.:企業の戦略・SWOT・財務情報
    U.P. Hotels Ltd. - Strategy, SWOT and Corporate Finance Report Summary U.P. Hotels Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Charles River Laboratories International Inc (CRL):製薬・医療:M&Aディール及び事業提携情報
    Summary Charles River Laboratories International Inc (Charles River) is a contract research organization (CRO) that provides essential products and services to accelerate the research, drug discovery and development. It offers various basic research, drug discovery and safety assessment services. Th …
  • Huntington Memorial Hospital:企業の戦略的SWOT分析
    Huntington Memorial Hospital - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Airasia Group Berhad:企業の戦略・SWOT・財務分析
    Airasia Group Berhad - Strategy, SWOT and Corporate Finance Report Summary Airasia Group Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Servair:企業の戦略・SWOT・財務分析
    Servair - Strategy, SWOT and Corporate Finance Report Summary Servair - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • Shire Plc (SHP):製薬・医療:M&Aディール及び事業提携情報
    Summary Shire Plc (Shire) is a biotechnology company that focuses on the research, development, manufacturing, marketing, distribution and sale of novel pharmaceuticals to treat patients with rare diseases and other highly specialized conditions. It provides products across various therapeutic areas …
  • Qurient Co Ltd (115180):製薬・医療:M&Aディール及び事業提携情報
    Summary Qurient Co Ltd (Qurient) is a pharmaceutical company that offers development of new drugs for unmet medical needs. The company provides portfolio of pipeline products such as Q301, Q203, Q701, 5LO INH and CDK7 INH, among others. It is developing products for the treatment of atopic dermatiti …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆